Guidelines for the first-line treatment of restless legs syndrome/Willis–Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation

•Prevention of augmentation may be started by considering using medications such as α2δ ligands for initial RLS treatment.•If treatment is initiated with dopaminergic drugs, the dose should be kept low and not exceed that recommended for RLS.•Patients with low iron stores should be given appropriate...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Sleep medicine Ročník 21; s. 1 - 11
Hlavní autoři:	Garcia-Borreguero, Diego, Silber, Michael H., Winkelman, John W., Högl, Birgit, Bainbridge, Jacquelyn, Buchfuhrer, Mark, Hadjigeorgiou, Georgios, Inoue, Yuichi, Manconi, Mauro, Oertel, Wolfgang, Ondo, William, Winkelmann, Juliane, Allen, Richard P.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier B.V 01.05.2016
Témata:	Algorithm Alpha 2 delta ligands Augmentation Consensus Dopamine agents Dopamine Agonists - adverse effects Dopamine Agonists - therapeutic use Drug Synergism Evidence-Based Medicine Humans Neurology Practice Guidelines as Topic Prevention Restless legs syndrome Restless Legs Syndrome - drug therapy Sleep Medicine Augmentation Prevention Restless legs syndrome Dopamine agents Alpha 2 delta ligands Algorithm
ISSN:	1389-9457, 1878-5506, 1878-5506
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!